| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521640 Method for interviewing neuronal death using sulfasalazine |
| 02/18/2003 | US6521625 Anticaogulants |
| 02/18/2003 | US6521614 N-(amidinophenyl)cyclourea analogs as factor Xa inhibitors |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521253 Low molecular weight peptide thrombin inhibitor having pH dependent solubility and a combination of microcrystalline cellulose and sodium starch glycollate |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/15/2003 | CA2397371A1 Pharmaceutical combinations for the treatment of neurodegenerative diseases |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012432A1 Erythropoietin and anti-tumor necrosis factor alpha combination therapy |
| 02/13/2003 | WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012030A2 Isoform-selective inhibitors and activators of pde3 cyclic |
| 02/13/2003 | WO2003011880A1 Glucopyrano syloxybenzyl benzene derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 02/13/2003 | WO2003011872A1 Platelet adp receptor inhibitors |
| 02/13/2003 | WO2003011866A1 Porphyrin-metal complexes and oxygen infusions containing the same |
| 02/13/2003 | WO2003011858A1 Substituted isoindoles and e use thereof |
| 02/13/2003 | WO2003011855A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011827A1 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives |
| 02/13/2003 | WO2003011810A1 Method for the nitration of phenolic compounds |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011313A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 02/13/2003 | WO2003011285A1 BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES |
| 02/13/2003 | WO2003011277A2 Methods to mobilize progenitor/stem cells |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2003011222A2 Thrombin inhibitors |
| 02/13/2003 | WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/13/2003 | WO2003011213A2 Method for treating diabetes and obesity |
| 02/13/2003 | WO2003011106A2 Internal image antibodies for optical imaging and therapy |
| 02/13/2003 | WO2003011055A1 Nutritional composition preventing bacterial overgrowth |
| 02/13/2003 | WO2002089730A3 Compounds and methods for the modulation of cd154 |
| 02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
| 02/13/2003 | WO2002074231A3 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | US20030033088 Method of generating chemical compounds having desired properties |
| 02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032663 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 02/13/2003 | US20030032626 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 02/13/2003 | US20030032618 Pharmaceutical combinations |
| 02/13/2003 | US20030032610 Administering one or more oligonucleotides which share at least 50% nucleotide sequence identity with (TTAGGG)n or oligonucleotides which share at least 50% nucleotide sequence identity with the human telomere overhang repeat. |
| 02/13/2003 | US20030032179 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/13/2003 | US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke |
| 02/13/2003 | US20030031627 For diagnosis and therapy |
| 02/13/2003 | CA2468925A1 Platelet adp receptor inhibitors |
| 02/13/2003 | CA2456192A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456177A1 Erythropoietin and anti-tumor necrosis factor alpha combination therapy |
| 02/13/2003 | CA2456092A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 02/13/2003 | CA2455772A1 Substituted isoindoles and their use |
| 02/13/2003 | CA2455179A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | CA2455100A1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454935A1 Method for the nitration of phenolic compounds |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/12/2003 | EP1283264A2 Interleukin-3 (IL-3) mutant polypeptides |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1282693A1 Human coagulation factor vii variants |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282592A2 Use of amines |
| 02/12/2003 | EP1282444A1 Antithrombotic agents |
| 02/12/2003 | EP1282439A1 PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR |
| 02/12/2003 | EP1282438A1 Pharmaceutical composition comprising a factor viia and a factor xiii |
| 02/12/2003 | EP1189899B1 Pyrazinone thrombin inhibitors |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP0820292B1 Inhibition of c. difficile infections by indigestible oligosaccharides |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | CN1396928A Process for preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 02/12/2003 | CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396908A Palatable arginine compounds and uses thereof for cardiovascular health |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1396825A Composition, kit for benefitting cardiovasaclaire and method |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396180A Process for preparing cross-linked haematoglobin as substitute of red blood cell |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395939A Compound of solanesol and its preparing process |
| 02/12/2003 | CN1101220C Thrombolytic medicine and its preparation process |
| 02/12/2003 | CN1101206C Hematopoietic oral liquid and its preparing process |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518274 Use of cyclopentabenzofuran-derivatives for combating (NF-κB)-dependent diseases |
| 02/11/2003 | US6518269 Cancer treatment |
| 02/11/2003 | US6518244 Cardiovascular disorders |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518010 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 02/11/2003 | US6517889 Eliminating or minimizing coating material located within openings; contacting with coating solution then running and rotating a thread through the lumen |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/08/2003 | CA2396616A1 Modified cdna for high expression levels of factor viii and its derivatives |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |